Determine and Perform Inter-Laboratory Comparison of Incremental Area Under the Curve (iAUC) of Glycaemia for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine and Perform Inter-Laboratory Comparison of the Glucose Cmax for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine and Perform Inter-Laboratory Comparison of the Blood Glucose Delta Peak for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine and Perform Inter-Laboratory Comparison of Insulinemic Index for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine and Perform Inter-Laboratory Comparison of the Incremental Area Under the Curve (iAUC) of Insulinemia for Each of the 6 Food Products [ Time Frame: 01-20 minutes ] [ Designated as safety issue: No ]

Determination and Perform Inter-Laboratory Comparison of Insulin Cmax for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine and Perform Inter-Laboratory Comparison of the Blood Insulin Delta Peak for Each of the 6 Food Products [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine the Intra-Laboratory Variability for the iAUC of Glycaemia [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Determine the Intra-Laboratory Variability of the iAUC of Insulinemia [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Taking any regular prescription medication at the time of inclusion that should interfere with carbohydrate metabolism (except regular oral contraception medication, thyroid replacement therapy)

Female who is pregnant (positive test results), lactating, planning pregnancy or not using acceptable contraceptive.

Subject having taken part in another clinical trial within the last week.

Subject currently taking part in another clinical trial or being in the exclusion period of another clinical trial.

Subject undergoing general anaesthesia in the month prior to inclusion.

Subject in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01870570